Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2025) 110 EP126 | DOI: 10.1530/endoabs.110.EP126

ECEESPE2025 ePoster Presentations Adrenal and Cardiovascular Endocrinology (170 abstracts)

Prevalence and evolution of diabetes in cushing’s syndrome: a 31-year retrospective study

Baltagi Myriam 1 , Ibtissem Ben Nacef 1 , Sawsen Essayeh 1 , Sabrine Mekni 1 , Rihab Laamouri 1 , Khiari Karima 1 & Rojbi Imen 1


1Hospital of Charles Nicolle, Tunis, Tunisia


JOINT2254

Introduction: Cushing’s syndrome (CS) is known to induce hyperglycemia, but the long-term prevalence and evolution of diabetes in CS remain poorly understood. This study aims to evaluate the prevalence and evolution of diabetes in CS patients over a 31-year period.

Methods: A retrospective analysis was conducted on 22 patients diagnosed with CS at the Endocrinology Department of Charles Nicolle Hospital. Data collected included demographics, clinical features, cortisol levels, and diabetes status at diagnosis, treatment initiation, and follow-up.

Results: The majority of patients (68%) presented with diabetes at the time of diagnosis, with 32% showing prediabetes. Following successful treatment and remission of hypercortisolism, 70% showed significant improvement in fasting blood glucose and HbA1c levels. Notably, there was a correlation between baseline cortisol levels and glycemic control, with higher cortisol levels associated with poorer control.

Discussion: These findings underscore the significant impact of hypercortisolism on glycemic control. The improvement in glucose metabolism after cortisol suppression further highlights the importance of managing Cushing’s syndrome effectively to mitigate diabetes-related complications.

Conclusion: Cushing’s syndrome has a substantial impact on the development and progression of diabetes. Remission of hypercortisolism leads to significant improvements in glycemic control, emphasizing the need for early diagnosis and targeted treatment to reduce diabetes burden in these patients.

Volume 110

Joint Congress of the European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE) 2025: Connecting Endocrinology Across the Life Course

European Society of Endocrinology 
European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches